Abstract
Tularemia is a rare infectious disease caused by a small pleomorphic, gram-negative rod, Francisella tularensis. Patients who acquire the disease have symptoms and signs that relate to the portals of entry of the bacteria: oculoglandular, ulceroglandular, pneumonic, and typhoidal. This infectious disease has been thoroughly studied through induced infections in volunteers; hence, a considerable body of data has been accumulated in a quantitative fashion about the pathogenicity of tularemia bacilli in humans. Man appears to be one of the most susceptible mammalian hosts studied: fewer than 50 organisms can cause disease whether administered intradermally or by the respiratory route.(42) The usual sources of infections are animals, especially cottontail rabbits, voles, and muskrats. Humans acquire the disease by direct contact or by bites of the ticks, mosquitos, deerflies, and other insects that infest such animals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander, M. M., Wright, G. G., and Baldwin, A. C., Observations on the agglutination of polysaccharide-treated erythrocytes by tularemia antisera, J. Exp. Med. 91:561–566 (1950).
Barbeito, M. S., Alg, R. L., and Wedum, A. G., Infectious bacterial aerosol from dropped petri dish cultures, Am. J. Med. Technol. 27:318–322 (1961).
Bell, J. F., Ecology of tularemia in North America, J.Jinsen Med. 11:33–44 (1965).
Bellanti, J.A., Beuscher, E. L., Brandt, W. E., Dangerfield, H. G., and Crozier, D., Characterization of human serum and nasal hemagglutinating antibody to Francisella tularensis, J. Immunol. 98:171–178 (1967).
Bivin, W. S., and Hogge, A. L., Jr., Quantitation of susceptibility of swine to infection with Pastuerella tularensis, Am. J. Vet. Res. 28:1619–1621 (1967).
Buchanan, T. M., Brooks, G. F., and Brachman, P. S., The tularemia skin test-325 skin tests in 210 persons: Serologic correlation and review of the literature, Ann. Intern. Med. 74:336–343 (1971).
Burnett, T. W., Tularemia in a Rocky Mountain sector of the western front, Mil. Surg. 78:193–199 (1936).
Canonico, P. G., McManus, A. T., Mangiafico, J. A., Sammons, L. S., McGann, V. G., and Dangerfield, H. G., Temporal appearance of opsonizing antibody to Francisella tularensis: Detection by a radiometabolic assay, Infect. Immun. 11:466–469 (1975).
Dahlstrand, S., Ringertz, O., and Zetterberg, B., Airborne tularemia in Sweden, Scand. J. Infect. Dis. 3:7–16 (1971).
Eigelsbach, H. T., and Downs, C. M., Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig, J. Immunol. 87:415–425 (1961).
Eigelsbach, H. T., Hunter, D. H., Janssen, W. A., Dangerfield, H. G., and Rabinowitz, S. G., Murine model for study of cell-mediated immunity: Protection against death from fully virulent Francisella tularensis infection, Infect. Immun. 12:999–1005 (1975).
Eigelsbach, H. T., Tulis, J. J., Mcgavran, M. H., and White, J. D., Live tularemia vaccine. I. Host-parasite relationship in monkeys vaccinated intracutaneously or aerogenically, J. Bacteriol. 84:1020–1027 (1962).
Francis, E., Deer-fly fever: A disease of man of hitherto unknown etiology, Public Health Rep. 34:2061–2062 (1919).
Francis, E., The occurrence of tularemia in nature, as a disease of man, Public Health Rep. 36:1731 (1921).
Francis, E., and Mayne B., Experimental transmission of tularemia by flies of the species Chryops discalis, Public Health Rep. 36:1738–1746 (1921).
Gaiskii, N. A., Altareva, N. D., and Lennik, T. G., Rapidity of the appearance and length of persistence of immunity after vaccination with tularemia vaccine, in: History and Incidence of Tularemia in the Soviet Unit-A Review (R. Pollitzer, ed.), pp. 125–136, Institute of Contemporary Russian Studies, Fordham University, New York, 1967.
Gallivan, M. V. E., Davis, W. A., III, Garagusi, V. F., Paris, A. L., and Lack, E. E., Fatal cat-transmitted tularemia: Demonstration of the organism in tissue, South Med. J. 73:240–242 (1980).
Horne, H., En lemeng og marsvintest, Nor. Vet.Tidsskr. 23:16 (1911).
Hornick, R. B., Dawkins, A. T., Eigelsbach, H. T., and Tulis, J. J., Oral tularemia vaccine in man, Antimicrob. Agents Chemother.-1966, pp. 11–14 (1967).
Hornick, R. B., and Eigelsbach, H. T., Aerogenic immunization of man with live tularemia vaccine, Bacteriol. Rev. 30:532–538 (1966).
Hunt, J. S., Pleuropulmonary tularemia: Observations on 12 cases treated with streptomycin, Ann. Intern. Med. 26:263–276 (1947).
Jellison, W. L., Owen, C. R., Bell, J. F., and Kohls, G. M., Tularemia and animal populations: Ecology and epizootiology, Wildl. Dis., No. 17 (1961).
Jellison, W. L., and Parker, R. R., Rodents, rabbits and tularemia in North America: Some zoological and epidemiological considerations, Am. J. Trop. Med. 25:349–362 (1945).
McCahan, G. R., Moody, M. D., and Hayes, F. A., An epizootic of tularemia among rabbits in northwestern South Carolina, Am. J. Hyg. 75:335–338 (1962).
McCoy, G. W., A plague-like disease of rodents, Public Health Bull. No. 43 (1911).
McCoy, G. W., and Chapin, C. W., Bacterium tularense, the cause of a plague-like disease of rodents, Public Health Bull. No. 53 (1912).
McGavran, M. H., White, J. D., Eigelsbach, H. T., and Kerpsack, R. W., Morphologic and immunohistochemical studies of the pathogenesis of infection and antibody formation subsequent to vaccination of Macaca irus with an attenuated strain of Pasteurella tularensis. I. Intracutaneous vaccination, Am. J. Pathol. 41:259–271 (1962).
Miller, R. P., and Bates, J. H., Pleuropulmonary tularemia: A review of 29 patients, Am. Rev. Respir. Dis. 99:31–41 (1969).
Moe, J. B., Canonico, P. G., Stookey, J. L., Powanda, M. C., and Cockerell, G. L., Pathogenesis of tularemia in immune and nonimmune rats, Am. J. Vet. Res. 36:1505–1510 (1975).
Nutter, J. E., and Myrvik, W. N., In vitro interactions between rabbit alveolar macrophages and Pasteurella tularensis, J. Bacteriol. 92:645–651 (1966).
Ohara, S., The Story of Yato-Byo (Tularemia in Japan), Obama, Fukushima City, 1955.
Overholt, E. I., and Tigertt, W. D., Roentgenographic manifestations of pulmonary tularemia, Radiology 74:758–765 (1960).
Overholt, E. L., Tigertt, W. D., Kadull, P. J., Ward, M. K., Charkes, N. D., Rene, R. M., Saltzman, T. E., and Stephens, M., An analysis of forty-two cases of laboratory-acquired tularemia: Treatment with broadspectrum antibiotics, Am. J. Med. 30:785 (1961).
Owen, C. R., and Buker, E. O., Factors involved in the transmission of Pasteurella tularensis from innoculated animals to healthy cage mates, J. Infect. Dis. 99:227–233 (1956).
Philip, R. N., Huntley, B., Lackman, D. B., and Comstock, G. W., Serologic and skin test evidence of tularemia infection among Alaskan Eskimos, Indians and Aleuts, J. Infect. Dis. 110:220–230 (1962).
Proctor, R. A., White, J. D., Ayala, E., and Canonico, P. G., Phagocytosis of Francisella tularensis by rhesus monkey peripheral leukocytes, Infect. Immun. 11:145–151 (1975).
Puntigam, F., Thorakale Formen in Seuchengeschehen der Tularämie in Österreich, Wien. Klin. Wochenschr. 72:813–816 (1960).
Riggs, J. L., Seiwald, R. J., Burckhalter, J. H., Downs, C. M., and Metcalf, T. G., Isothiocyanate compounds as fluorescent labeling agents for immune serum, Am. J. Pathol. 34:1081–1097 (1958).
Saslaw, S., and Carhart, S., Studies with tularemia vaccines in volunteers. III. Serologic aspects following intracutaneous or respiratory challenge in both vaccinated and nonvaccinated volunteers, Am. J. Med. Sci. 241:689–699 (1961).
Saslaw, S., and Carlisle, H. N., Studies with tularemia vaccines in volunteers. IV. Brucella agglutinins in vaccinated and nonvaccinated volunteers challenged with Pasteurella tularensis, Am. J. Med. Sci. 242:166–172 (1961).
Saslaw, S., Eigelsbach, H. T., Wilson, H. E., Prior, J. A., and Carhart, S., Tularemia vaccine study. I. Intracutaneous challenge. Arch. Intern. Med. 107:689–701 (1961).
Saslaw, S., Eigelsbach, H. T., Prior, J. A., Wilson, H. E., and Carhart, S., Tularemia vaccine study. II. Respiratory challenge, Arch. Intern. Med. 107:702–714 (1961).
Sawyer, W. D., Jemski, J. V., Hogge, A. L., Jr., Eigelsbach, H. T., Wolfe, E. K., Dangerfield, H. G., Gochenour, W. S., Jr., and Crozier, D., Effect of aerosol age on the infectivity of airborne Pasteurella tularensis for Macaca mulatta and man, J. Bacteriol. 91:2180–2184 (1966).
Sil’chenko, V. S., Epidemiological and clinical features of tularemia caused by waterborne infection, Zh. Mikrobiol. Epidemiol. Immunobiol. 28:788–795 (1957).
Stuart, B. M., and Pullen, R. L., Tularemic pneumonia: Review of American literature and report of 15 additional cases, Am. J. Med. Sci. 210:223–236 (1945).
Tärnvik, A., and LÖFgren, S., Stimulation Of human lymphocytes by a vaccine strain of Francisella tularensis, Infect. Immun. 12:951–957 (1975).
Tärnvik, A., Sandström, G., and LÖFgren, S., Time of lymphocyte response after onset of tularemia and after tularemia vaccination, J. Clin. Microbiol. 10:854–860 (1979).
Teutsch, S. M., Martone, W. J., Brink, E. W., Potter, M. E., Eliot, G., Hoxsie, R., Craven, R. B., and Kaufmann, A. F., Pneumonic tularemia on Martha’s Vineyard, N. Engl. J. Med. 301:826–828 (1979).
Vail, D. T., Bacillus tularense infection of the eye, Ophthalmol. Res. 23:487 (1914).
Waring, W. B., and Ruffin, J. J., A tick-borne epidemic of tularemia, N. Engl. J. Med. 234:137 (1946).
Wherry, W. B., A new bacterial disease of rodents transmissible to man, Public Health Rep. 29:3387 (1914).
White, J. D., Mcgavran, M. H., Prickett, P. A., Tulis, J. J., and Eigelsbach, H. T., Morphologic and immunohistochemical studies of the pathogenesis of infection and antibody formation subsequent to vaccination of Macaca irus with an attenuated strain of Pasteurella tularensis. II. Aerogenic vaccination, Am. J. Pathol. 41:405–413 (1962).
WHO. Annual Statistics, Infectious Diseases’ Cases and Deaths 2:1–204 (1978).
Young, L. S., Bicknell, D. S., Archer, B. G., Clinton, J. M., Leavens, L. J., Feeley, J. C., and Brachman, P. S., Tularemia epidemic: Vermont, 1968: Forty-seven cases linked to contact with muskrats, N. Engl. J. Med. 280:1253–1260 (1969).
Suggested Reading
Boyce, J. M., Recent trends in the epidemiology of tularemia in the United States. J. Infect. Dis. 131:197–199 (1975).
Brooks, G. F. and Buchanan, T. M., Tularemia in the United States: epidemiologic aspects in the 1960’s and followup of the outbreak of tularemia in Vermont. J. Infect. Dis. 121:357–359 (1970).
Butler, T., Plague and tularemia. Ped. Clin. N. A. 26:355–366 (1979).
Jellison, W. L., Owne, C. R., Bell, J. F., and Kohls, G. M., Tularemia and animal populations: Ecology and epizootiology, Wildl. Dis., No. 17 (1961).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hornick, R.B. (1982). Tularemia. In: Evans, A.S., Feldman, H.A. (eds) Bacterial Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1140-0_35
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1140-0_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1142-4
Online ISBN: 978-1-4757-1140-0
eBook Packages: Springer Book Archive